Status: Recruiting
Molecular and Functional Imaging in Monogenic PD.
In this study, the investigators aim to find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The findings will provide a deeper understanding of the brain changes in Parkinson's disease. More importantly, this study will help with the discovery and development of new medications aiming to delay progression of PD symptoms.
Participants needed: 45
Trial details
Age: 25-80Biological sex: AllType: ObservationalSponsor: University of ExeterUpdated: Oct 7, 2025Locations: 1
Eligibility criteria
All subjects must be judged by the investigator able to understand the nature, d... [+6]
Subjects lacking capacity according to investigator judgement. [+11]